Ridgway, Mildred R. External Author

Publications

Sort by

Selected publications

  • A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231DGynecologic Oncology2017 Academic Article GET IT
    Times cited: 1